Treatment of systemic mastocytosis with interferon-γ: failure after appearance of anti-IFN-γ antibodies

Abstract. We report a case of a patient with systemic mastocytosis who was treated with interferon-γ. Because of severe diarrhoea, nausea and weight loss due to mast cell infiltration of the gastric mucosa the patient received 150μg d-1 interferon-γ subcutan-eously for 10 months. During therapy, the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fiehn, Christoph (VerfasserIn) , Prümmer, O. (VerfasserIn) , Gallati, H. (VerfasserIn) , Heilig, Bernhard (VerfasserIn) , Hunstein, Werner (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 1995
In: European journal of clinical investigation
Year: 1995, Jahrgang: 25, Heft: 8, Pages: 615-618
ISSN:1365-2362
DOI:10.1111/j.1365-2362.1995.tb01754.x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1365-2362.1995.tb01754.x
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2362.1995.tb01754.x
Volltext
Verfasserangaben:C. Fiehn, O. Prümmer, H. Gallati, B. Heilig, W. Hunstein

MARC

LEADER 00000naa a2200000 c 4500
001 1942607954
003 DE-627
005 20251126143951.0
007 cr uuu---uuuuu
008 251126s1995 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1365-2362.1995.tb01754.x  |2 doi 
035 |a (DE-627)1942607954 
035 |a (DE-599)KXP1942607954 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Fiehn, Christoph  |d 1963-  |e VerfasserIn  |0 (DE-588)1076688268  |0 (DE-627)835256758  |0 (DE-576)170706672  |4 aut 
245 1 0 |a Treatment of systemic mastocytosis with interferon-γ  |b failure after appearance of anti-IFN-γ antibodies  |c C. Fiehn, O. Prümmer, H. Gallati, B. Heilig, W. Hunstein 
264 1 |c August 1995 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.11.2025 
520 |a Abstract. We report a case of a patient with systemic mastocytosis who was treated with interferon-γ. Because of severe diarrhoea, nausea and weight loss due to mast cell infiltration of the gastric mucosa the patient received 150μg d-1 interferon-γ subcutan-eously for 10 months. During therapy, the plasma concentrations of IL-3, IL-4 and GM-CSF, which seem to play a role in mast cell growth and differentiation were monitored. The patient had good symptomatic relief and the initially very high eosinophil counts in the pripheral blood showed a partial reduction. However, after 4 months of therapy the patient relapsed. In serum obtained after the relapse, but not in stored serum from the beginning of the therapy, neutralizing antibodies against interferon-γ were found. Therefore an initial response to the therapy and a secondary failure mediated by treatment-induced antibodies against recombinant interferon-γ might be suggested. Interferon-γ may be a well tolerated therapeutic option in systemic mastocytosis. However, treatment-induced neutralizing antibodies against recombinant interferon-γ should be considered if secondary treatment failure occurs. 
650 4 |a Antibodies 
650 4 |a granulocyte macrophage colony-stimulating factor in plasma 
650 4 |a interferon-γ therapy 
650 4 |a systemic mastocytosis 
700 1 |a Prümmer, O.  |e VerfasserIn  |4 aut 
700 1 |a Gallati, H.  |e VerfasserIn  |4 aut 
700 1 |a Heilig, Bernhard  |e VerfasserIn  |0 (DE-588)1211351513  |0 (DE-627)1699093865  |4 aut 
700 1 |a Hunstein, Werner  |d 1928-2012  |e VerfasserIn  |0 (DE-588)1012782662  |0 (DE-627)699775833  |0 (DE-576)345935667  |4 aut 
773 0 8 |i Enthalten in  |t European journal of clinical investigation  |d Oxford [u.a.] : Wiley-Blackwell, 1970  |g 25(1995), 8, Seite 615-618  |h Online-Ressource  |w (DE-627)320441423  |w (DE-600)2004971-7  |w (DE-576)091142695  |x 1365-2362  |7 nnas  |a Treatment of systemic mastocytosis with interferon-γ failure after appearance of anti-IFN-γ antibodies 
773 1 8 |g volume:25  |g year:1995  |g number:8  |g pages:615-618  |g extent:4  |a Treatment of systemic mastocytosis with interferon-γ failure after appearance of anti-IFN-γ antibodies 
856 4 0 |u https://doi.org/10.1111/j.1365-2362.1995.tb01754.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2362.1995.tb01754.x  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251126 
993 |a Article 
994 |a 1995 
998 |g 1012782662  |a Hunstein, Werner  |m 1012782662:Hunstein, Werner  |d 910000  |d 910100  |e 910000PH1012782662  |e 910100PH1012782662  |k 0/910000/  |k 1/910000/910100/  |p 5  |y j 
998 |g 1211351513  |a Heilig, Bernhard  |m 1211351513:Heilig, Bernhard  |d 50000  |e 50000PH1211351513  |k 0/50000/  |p 4 
998 |g 1076688268  |a Fiehn, Christoph  |m 1076688268:Fiehn, Christoph  |d 910000  |d 910100  |e 910000PF1076688268  |e 910100PF1076688268  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1942607954  |e 4814266383 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"recId":"1942607954","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 26.11.2025"],"title":[{"title_sort":"Treatment of systemic mastocytosis with interferon-γ","title":"Treatment of systemic mastocytosis with interferon-γ","subtitle":"failure after appearance of anti-IFN-γ antibodies"}],"person":[{"family":"Fiehn","given":"Christoph","display":"Fiehn, Christoph","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Prümmer, O.","given":"O.","family":"Prümmer"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Gallati, H.","given":"H.","family":"Gallati"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Heilig, Bernhard","given":"Bernhard","family":"Heilig"},{"family":"Hunstein","given":"Werner","display":"Hunstein, Werner","roleDisplay":"VerfasserIn","role":"aut"}],"relHost":[{"language":["eng"],"recId":"320441423","physDesc":[{"extent":"Online-Ressource"}],"disp":"Treatment of systemic mastocytosis with interferon-γ failure after appearance of anti-IFN-γ antibodiesEuropean journal of clinical investigation","type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"issue":"8","pages":"615-618","year":"1995","extent":"4","volume":"25","text":"25(1995), 8, Seite 615-618"},"pubHistory":["1.1970/71 -"],"id":{"zdb":["2004971-7"],"doi":["10.1111/(ISSN)1365-2362"],"eki":["320441423"],"issn":["1365-2362"]},"origin":[{"dateIssuedKey":"1970","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedDisp":"1970-","publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford [u.a.]"}],"title":[{"title_sort":"European journal of clinical investigation","subtitle":"the journal of the European Society for Clinical Investigation","title":"European journal of clinical investigation"}]}],"physDesc":[{"extent":"4 S."}],"id":{"doi":["10.1111/j.1365-2362.1995.tb01754.x"],"eki":["1942607954"]},"origin":[{"dateIssuedDisp":"August 1995","dateIssuedKey":"1995"}],"name":{"displayForm":["C. Fiehn, O. Prümmer, H. Gallati, B. Heilig, W. Hunstein"]}} 
SRT |a FIEHNCHRISTREATMENTO1995